CHARLES H HOOD FOUNDATION: Form 990PF, tax year 2020

View the entire original 990 at ProPublica ↗

Organization
CHARLES H HOOD FOUNDATION (EIN 04-3507847)
Tax period
2020-01-01 to 2020-12-31
Filed
2021-10-01
IRS object ID
202102749349100110
Schema version
2020v4.1
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2021-10-01T16:32:19-05:00ReturnTs
Tax Period End2020-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

FieldValueIRS element (for citing)
Preparer Firm EIN042571780PreparerFirmEIN

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1AAFCPAS INCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line150 WASHINGTON STREETAddressLine1Txt
CityWESTBOROUGHCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01581ZIPCd
FieldValueIRS element (for citing)
Return Type990PFReturnTypeCd
Tax Period Begin2020-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN043507847EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1CHARLES H HOOD FOUNDATIONBusinessNameLine1Txt
FieldValueIRS element (for citing)
Business Name ControlCHARBusinessNameControlTxt
Phone6176959439PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line12 BOYLSTON STREET 4TH FLOORAddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02116ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonNEIL SMILEYPersonNm
Person TitlePRESIDENT AND TREASURERPersonTitleTxt
Phone6176959439PhoneNum
Signature2021-09-24SignatureDt
Discuss With Paid PreparerYes (1)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstNEILPersonFirstNm
Person LastSMILEYPersonLastNm
FieldValueIRS element (for citing)
SSNXXX-XX-XXXXSSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonJOYCE RIPIANZI CPAPreparerPersonNm
PTINP00548581PTIN
Phone5083669100PhoneNum
Preparation2021-09-24PreparationDt

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer2TrustedCustomerCd
Authentication Assurance LevelAAL1AuthenticationAssuranceLevelCd
Identity Assurance LevelIAL1IdentityAssuranceLevelCd
FieldValueIRS element (for citing)
Tax2020TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990-PF IRS990PF

FieldValueIRS element (for citing)
Organization501c3 Exempt PFYes (X)Organization501c3ExemptPFInd
FMV Assets EOY$73,468,723FMVAssetsEOYAmt
Method Of Accounting CashYes (X)MethodOfAccountingCashInd

Analysis Of Revenue And Expenses AnalysisOfRevenueAndExpenses

FieldValueIRS element (for citing)
Schedule B Not RequiredYes (X)ScheduleBNotRequiredInd
Dividends Rev And Expnss$1,302,685DividendsRevAndExpnssAmt
Dividends Net Invst Incm$1,302,685DividendsNetInvstIncmAmt
Net Gain Sale Ast Rev And Expnss$860,251NetGainSaleAstRevAndExpnssAmt
Gross Sales Price$5,970,212GrossSalesPriceAmt
Cap Gain Net Incm Net Invst Incm$860,251CapGainNetIncmNetInvstIncmAmt
Incm Modifications Adj Net Incm$175,535IncmModificationsAdjNetIncmAmt
Other Income Rev And Expnss$180,014OtherIncomeRevAndExpnssAmt
Other Income Net Invst Incm$0OtherIncomeNetInvstIncmAmt
Total Rev And Expnss$2,342,950TotalRevAndExpnssAmt
Total Net Invst Incm$2,162,936TotalNetInvstIncmAmt
Total Adj Net Incm$175,535TotalAdjNetIncmAmt
Comp Ofcr Dir Trst Rev And Expnss$0CompOfcrDirTrstRevAndExpnssAmt
Comp Ofcr Dir Trst Net Invst Incm$0CompOfcrDirTrstNetInvstIncmAmt
Comp Ofcr Dir Trst Dsbrs Chrtbl$0CompOfcrDirTrstDsbrsChrtblAmt
Legal Fees Rev And Expnss$28,703LegalFeesRevAndExpnssAmt
Legal Fees Net Invst Incm$0LegalFeesNetInvstIncmAmt
Legal Fees Dsbrs Chrtbl$28,703LegalFeesDsbrsChrtblAmt
Accounting Fees Rev And Expnss$16,253AccountingFeesRevAndExpnssAmt
Accounting Fees Net Invst Incm$0AccountingFeesNetInvstIncmAmt
Accounting Fees Chrtbl Prps$16,253AccountingFeesChrtblPrpsAmt
Other Prof Fees Rev And Expnss$106,525OtherProfFeesRevAndExpnssAmt
Other Prof Fees Net Invst Incm$90,762OtherProfFeesNetInvstIncmAmt
Other Prof Fees Dsbrs Chrtbl$15,763OtherProfFeesDsbrsChrtblAmt
Taxes Rev And Expnss$36,521TaxesRevAndExpnssAmt
Taxes Net Invst Incm$36,521TaxesNetInvstIncmAmt
Taxes Dsbrs Chrtbl$0TaxesDsbrsChrtblAmt
Trav Conf Meeting Rev And Expnss$4,456TravConfMeetingRevAndExpnssAmt
Trav Conf Meeting Net Invst Incm$0TravConfMeetingNetInvstIncmAmt
Trav Conf Meeting Dsbrs Chrtbl$4,456TravConfMeetingDsbrsChrtblAmt
Other Expenses Rev And Expnss$210,764OtherExpensesRevAndExpnssAmt
Other Expenses Net Invst Incm$0OtherExpensesNetInvstIncmAmt
Other Expenses Dsbrs Chrtbl$210,764OtherExpensesDsbrsChrtblAmt
Tot Opr Expenses Rev And Expnss$403,222TotOprExpensesRevAndExpnssAmt
Tot Opr Expenses Net Invst Incm$127,283TotOprExpensesNetInvstIncmAmt
Tot Opr Expenses Dsbrs Chrtbl$275,939TotOprExpensesDsbrsChrtblAmt
Contri Paid Rev And Expnss$2,059,212ContriPaidRevAndExpnssAmt
Contri Paid Dsbrs Chrtbl$2,059,212ContriPaidDsbrsChrtblAmt
Total Expenses Rev And Expnss$2,462,434TotalExpensesRevAndExpnssAmt
Total Expenses Net Invst Incm$127,283TotalExpensesNetInvstIncmAmt
Total Expenses Dsbrs Chrtbl$2,335,151TotalExpensesDsbrsChrtblAmt
Excess Revenue Over Expenses-$119,484ExcessRevenueOverExpensesAmt
Net Investment Income$2,035,653NetInvestmentIncomeAmt
Adjusted Net Income$175,535AdjustedNetIncomeAmt

Form990 PF Balance Sheets Form990PFBalanceSheetsGrp

FieldValueIRS element (for citing)
Sav And Temp Cash Invst BOY$502,310SavAndTempCashInvstBOYAmt
Sav And Temp Cash Invst EOY$388,809SavAndTempCashInvstEOYAmt
Sav And Temp Cash Invst EOYFMV$388,809SavAndTempCashInvstEOYFMVAmt
Corporate Stock BOY$47,014,599CorporateStockBOYAmt
Corporate Stock EOY$51,980,735CorporateStockEOYAmt
Corporate Stock EOYFMV$51,980,735CorporateStockEOYFMVAmt
Corporate Bonds BOY$15,038,832CorporateBondsBOYAmt
Corporate Bonds EOY$15,513,323CorporateBondsEOYAmt
Corporate Bonds EOYFMV$15,513,323CorporateBondsEOYFMVAmt
Other Investments BOY$2,964,148OtherInvestmentsBOYAmt
Other Investments EOY$3,465,892OtherInvestmentsEOYAmt
Other Investments EOYFMV$3,465,892OtherInvestmentsEOYFMVAmt
Other Assets BOY$1,307,000OtherAssetsBOYAmt
Other Assets EOY$2,119,964OtherAssetsEOYAmt
Other Assets EOYFMV$2,119,964OtherAssetsEOYFMVAmt
Total Assets BOY$66,826,889TotalAssetsBOYAmt
Total Assets EOY$73,468,723TotalAssetsEOYAmt
Total Assets EOYFMV$73,468,723TotalAssetsEOYFMVAmt
Total Liabilities BOY$0TotalLiabilitiesBOYAmt
Total Liabilities EOY$0TotalLiabilitiesEOYAmt
Org Does Not Follow FASB117Yes (X)OrgDoesNotFollowFASB117Ind
Capital Stock BOY$59,300,755CapitalStockBOYAmt
Capital Stock EOY$59,300,755CapitalStockEOYAmt
Additional Paid In Capital BOY$0AdditionalPaidInCapitalBOYAmt
Additional Paid In Capital EOY$0AdditionalPaidInCapitalEOYAmt
Retained Earning BOY$7,526,134RetainedEarningBOYAmt
Retained Earning EOY$14,167,968RetainedEarningEOYAmt
Tot Net Ast Or Fund Balances BOY$66,826,889TotNetAstOrFundBalancesBOYAmt
Tot Net Ast Or Fund Balances EOY$73,468,723TotNetAstOrFundBalancesEOYAmt
Total Liabilities Net Ast BOY$66,826,889TotalLiabilitiesNetAstBOYAmt
Total Liabilities Net Ast EOY$73,468,723TotalLiabilitiesNetAstEOYAmt

Chg In Net Assets Fund Balances ChgInNetAssetsFundBalancesGrp

FieldValueIRS element (for citing)
Tot Net Ast Or Fund Balances BOY$66,826,889TotNetAstOrFundBalancesBOYAmt
Excess Revenue Over Expenses-$119,484ExcessRevenueOverExpensesAmt
Other Increases$6,877,676OtherIncreasesAmt
Subtotal$73,585,081SubtotalAmt
Other Decreases$116,358OtherDecreasesAmt
Tot Net Ast Or Fund Balances EOY$73,468,723TotNetAstOrFundBalancesEOYAmt

Cap Gains Loss Tx Invst Incm Detail CapGainsLossTxInvstIncmDetail

Cap Gains Loss Tx Invst Incm CapGainsLossTxInvstIncmGrp

FieldValueIRS element (for citing)
PropertyPUBLICLY TRADED SECURITIESPropertyDesc
Gross Sales Price$5,970,212GrossSalesPriceAmt
Cost Or Other Basis$5,109,961CostOrOtherBasisAmt
Gain Or Loss$860,251GainOrLossAmt
Gains Minus Excess Or Losses$860,251GainsMinusExcessOrLossesAmt
FieldValueIRS element (for citing)
Capital Gain Net Income$860,251CapitalGainNetIncomeAmt

Excise Tax Based On Invst Incm ExciseTaxBasedOnInvstIncmGrp

FieldValueIRS element (for citing)
Investment Income Excise Tax$28,296InvestmentIncomeExciseTaxAmt
Tax Under Section511$0TaxUnderSection511Amt
Subtotal$28,296SubtotalAmt
Subtitle A Tax$0SubtitleATaxAmt
Tax Based On Investment Income$28,296TaxBasedOnInvestmentIncomeAmt
Estimated Plus Ovpmt Incm Tx$39,516EstimatedPlusOvpmtIncmTxAmt
Exempt Frgn Org Tax Wthld At Srce$0ExemptFrgnOrgTaxWthldAtSrceAmt
Extsn Request Income Tax Paid$0ExtsnRequestIncomeTaxPaidAmt
Backup Withholding Withheld$0BackupWithholdingWithheldAmt
Total Payments And Credits$39,516TotalPaymentsAndCreditsAmt
Es Penalty$0EsPenaltyAmt
Overpayment$11,220OverpaymentAmt
Applied To ES Tax$11,220AppliedToESTaxAmt
Refund$0RefundAmt

Statements Regarding Acty StatementsRegardingActyGrp

FieldValueIRS element (for citing)
Legislative Political Acty0LegislativePoliticalActyInd
More Than100 Spent0MoreThan100SpentInd
Form1120 POL Filed0Form1120POLFiledInd
Section4955 Organization Tax$0Section4955OrganizationTaxAmt
Section4955 Managers Tax$0Section4955ManagersTaxAmt
Tax Reimbursed$0TaxReimbursedAmt
Activities Not Previously Rpt0ActivitiesNotPreviouslyRptInd
Changes To Articles Or Bylaws0ChangesToArticlesOrBylawsInd
Unrelated Bus Incm Over LimitYes (1)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (1)Form990TFiledInd
Organization Dissolved Etc0OrganizationDissolvedEtcInd
Section508e Rqr SatisfiedYes (1)Section508eRqrSatisfiedInd
At Least5000 In AssetsYes (1)AtLeast5000InAssetsInd
Org Report Or Register StateMAOrgReportOrRegisterStateCd
Form990 PF Filed With Atty GenYes (1)Form990PFFiledWithAttyGenInd
Private Operating Foundation0PrivateOperatingFoundationInd
New Substantial Contributors0NewSubstantialContributorsInd
Own Controlled EntityYes (1)OwnControlledEntityInd
Donor Advised Fund0DonorAdvisedFundInd
Comply With Public Insp RqrYes (1)ComplyWithPublicInspRqrInd
Website AddressHTTPS://HRIA.ORG/TMF/HOOD/WebsiteAddressTxt
Individual With BooksAAFCPASIndividualWithBooksNm
Phone5083669100PhoneNum

Location Of Books US Address LocationOfBooksUSAddress

FieldValueIRS element (for citing)
Address Line150 WASHINGTON STREETAddressLine1Txt
CityWESTBOROUGHCityNm
State AbbreviationMAStateAbbreviationCd
ZIP01581ZIPCd
FieldValueIRS element (for citing)
Foreign Accounts Question0ForeignAccountsQuestionInd

Statements Regarding Acty4720 StatementsRegardingActy4720Grp

FieldValueIRS element (for citing)
Sale Or Exch Disqualified Prsn0SaleOrExchDisqualifiedPrsnInd
Brrw Or Lend Disqualified Prsn0BrrwOrLendDisqualifiedPrsnInd
Furn Goods Disqualified Prsn0FurnGoodsDisqualifiedPrsnInd
Pay Comp Disqualified PrsnYes (1)PayCompDisqualifiedPrsnInd
Transfer Ast Disqualified Prsn0TransferAstDisqualifiedPrsnInd
Payment To Government Official0PaymentToGovernmentOfficialInd
Acts Fail To Qlfy As Exceptions0ActsFailToQlfyAsExceptionsInd
Uncorrected Prior Acts0UncorrectedPriorActsInd
Undistributed Income PY0UndistributedIncomePYInd
Business HoldingsYes (1)BusinessHoldingsInd
Excess Business Holdings0ExcessBusinessHoldingsInd
Jeopardy Investments0JeopardyInvestmentsInd
Uncorrected PY Jeopardy Invst0UncorrectedPYJeopardyInvstInd
Influence Legislation0InfluenceLegislationInd
Influence Election0InfluenceElectionInd
Grants To Individuals0GrantsToIndividualsInd
Grants To OrganizationsYes (1)GrantsToOrganizationsInd
Noncharitable Purpose0NoncharitablePurposeInd
Transactions Fail To Qlfy As Exc0TransactionsFailToQlfyAsExcInd
Maintained Expenditure RspnsYes (1)MaintainedExpenditureRspnsInd
Rcv Fnds To Pay Prsnl Bnft Cntrct0RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct0PayPremiumsPrsnlBnftCntrctInd
Prohibited Tax Shelter Trans0ProhibitedTaxShelterTransInd
Subj To Tax Rmnrtn Ex Prcht Pymt0SubjToTaxRmnrtnExPrchtPymtInd

Officer Dir Trst Key Empl Info OfficerDirTrstKeyEmplInfoGrp

Officer Dir Trst Key Empl OfficerDirTrstKeyEmplGrp (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdTitleTitleTxtAverage Hrs Per Wk Devoted To PosAverageHrsPerWkDevotedToPosRtCompensationCompensationAmtEmployee Benefit ProgramEmployeeBenefitProgramAmtExpense Account Other AllwncExpenseAccountOtherAllwncAmt
NEIL SMILEY
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116PRESIDENT AND TREASURER1.00$0$0$0
JOHN O PARKER JR
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116VICE PRESIDENT AND CLERK1.00$0$0$0
ROBERT C BOUTWELL
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
BARBARA BULA
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
BRENDON BULA
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
ELIZABETH HOOD
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
CLAY SMILEY
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116TRUSTEE1.00$0$0$0
FieldValueIRS element (for citing)
Comp Of Hghst Pd Empl Or NONENONECompOfHghstPdEmplOrNONETxt
Other Employee Paid Over50k0OtherEmployeePaidOver50kCnt

Compensation Of Hghst Pd Cntrct CompensationOfHghstPdCntrctGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdService TypeServiceTypeTxtCompensationCompensationAmt
HEALTH RESOURCES IN ACTION
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116ADMINISTRATIVE FEES$131,820
PRIME BUCHHOLZ
273 CORPORATE DRIVE SUITE 250PORTSMOUTHNH03801INVESTMENT ADVISORY SERVICES$75,000
FieldValueIRS element (for citing)
Contractor Paid Over50k0ContractorPaidOver50kCnt

Sum Of Program Related Invst SumOfProgramRelatedInvstGrp

FieldValueIRS element (for citing)
Description1MESENTECH, INC. - BRITISH COLUMBIA, CANADASAFE - SIMPLE AGREEMENT FOR FUTURE EQUITYDescription1Txt
Expenses1$250,000Expenses1Amt
Description2ANIDA PHARMA - CAMBRIDGE, MACONVERTIBLE PROMISSORY NOTEDescription2Txt
Expenses2$250,000Expenses2Amt
All Other Program Rltd Invst Tot$300,000AllOtherProgramRltdInvstTotAmt
Total$800,000TotalAmt

Minimum Investment Return MinimumInvestmentReturnGrp

FieldValueIRS element (for citing)
Average Monthly FMV Of Sec$63,357,772AverageMonthlyFMVOfSecAmt
Average Monthly Cash Balances$250,829AverageMonthlyCashBalancesAmt
FMV All Other Noncharitable Ast$602,701FMVAllOtherNoncharitableAstAmt
Total FMV Of Unused Assets$64,211,302TotalFMVOfUnusedAssetsAmt
Reduction Claimed$0ReductionClaimedAmt
Acquisition Indebtedness$0AcquisitionIndebtednessAmt
Adjusted Total FMV Of Unused Ast$64,211,302AdjustedTotalFMVOfUnusedAstAmt
Cash Deemed Charitable$963,170CashDeemedCharitableAmt
Net Vl Noncharitable Assets$63,248,132NetVlNoncharitableAssetsAmt
Minimum Investment Return$3,162,407MinimumInvestmentReturnAmt

Distributable Amount DistributableAmountGrp

FieldValueIRS element (for citing)
Minimum Investment Return$3,162,407MinimumInvestmentReturnAmt
Tax Based On Investment Income$28,296TaxBasedOnInvestmentIncomeAmt
Income Tax$448IncomeTaxAmt
Total Tax$28,744TotalTaxAmt
Distributable Before Adj$3,133,663DistributableBeforeAdjAmt
Recoveries Qualfied Distri$175,535RecoveriesQualfiedDistriAmt
Distributable Before Ded$3,309,198DistributableBeforeDedAmt
Deduction From Distributable$0DeductionFromDistributableAmt
Distributable As Adjusted$3,309,198DistributableAsAdjustedAmt

Qualifying Distri Part XII QualifyingDistriPartXIIGrp

FieldValueIRS element (for citing)
Expenses And Contributions$2,335,151ExpensesAndContributionsAmt
Program Related Invst Total$800,000ProgramRelatedInvstTotalAmt
Qualifying Distributions$3,135,151QualifyingDistributionsAmt
Pct Sect4940e Org Net Invst Incm$0PctSect4940eOrgNetInvstIncmAmt
Adjusted Qualifying Distri$3,135,151AdjustedQualifyingDistriAmt

Undistributed Income UndistributedIncomeGrp

FieldValueIRS element (for citing)
Distributable As Adjusted$3,309,198DistributableAsAdjustedAmt
Undistributed Income PY$2,911,960UndistributedIncomePYAmt
Total For Prior Years$0TotalForPriorYearsAmt
Total Excess Distribution Cyov$0TotalExcessDistributionCyovAmt
Qualifying Distributions$3,135,151QualifyingDistributionsAmt
Applied To Year1$2,911,960AppliedToYear1Amt
Applied To Prior Years$0AppliedToPriorYearsAmt
Treated As Distri From Corpus$0TreatedAsDistriFromCorpusAmt
Applied To Current Year$223,191AppliedToCurrentYearAmt
Remaining Distri From Corpus$0RemainingDistriFromCorpusAmt
Excess Distri Cyov App CY Corpus$0ExcessDistriCyovAppCYCorpusAmt
Excess Distribution Cyov App CY$0ExcessDistributionCyovAppCYAmt
Total Corpus$0TotalCorpusAmt
Prior Year Undistributed Incm$0PriorYearUndistributedIncmAmt
Prior Year Deficiency Or Tax$0PriorYearDeficiencyOrTaxAmt
Taxable1$0Taxable1Amt
Taxable2$0Taxable2Amt
Undistributed Income CY$3,086,007UndistributedIncomeCYAmt
Corpus Distri170b1 E Or4942g3$0CorpusDistri170b1EOr4942g3Amt
Excess Distri Cyov From Yr5$0ExcessDistriCyovFromYr5Amt
Excess Distri Cyov To Next Yr$0ExcessDistriCyovToNextYrAmt

Supplementary Information SupplementaryInformationGrp

Application Submission Info ApplicationSubmissionInfoGrp

FieldValueIRS element (for citing)
Recipient PersonCHARLENE MANCUSI PROGRAM OFFICER HRRecipientPersonNm

Recipient US Address RecipientUSAddress

FieldValueIRS element (for citing)
Address Line12 BOYLSTON STREET 4TH FLOORAddressLine1Txt
CityBOSTONCityNm
State AbbreviationMAStateAbbreviationCd
ZIP02116ZIPCd
FieldValueIRS element (for citing)
Recipient Phone6176959439RecipientPhoneNum
Recipient Email AddressCMANCUSI@HRIA.ORGRecipientEmailAddressTxt
Form And Info And MaterialsAPPLICATION FORMS AVAILABLE AT WWW.TMFGRANTS.ORG/HOODFormAndInfoAndMaterialsTxt
Submission DeadlinesANNUALLY MARCH AND OCTOBERSubmissionDeadlinesTxt
Restrictions On AwardsRESTRICTED TO PEDIATRIC RESEARCHRestrictionsOnAwardsTxt

Grant Or Contribution Pd Dur Yr GrantOrContributionPdDurYrGrp (27 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line2RecipientUSAddress/AddressLine2Txt
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - MICROVASCULAR NETWORKS ON A CHIP TO INVESTIGATE HOW HYPERGLYCEMIA INDUCES MICROANGIOPATHY IN TYPE 1 DIABETES$82,500
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - REAL-TIME PREDICTION AND INTERVENTION FOR IMPENDING ACUTE KIDNEY INJURY IN HOSPITALIZED CHILDREN$82,500
BOSTON CHILDRENS HOSPITAL
PO BOX 414413BOSTONMA022414413PCCHILD HEALTH RESEARCH AWARD - SYSTEMATIC DISCOVERY AND CORRECTION OF SPLICING DEFECTS CAUSED BY RETROELEMENT INSERTIONS$82,500
MASSACHUSETTS EYE AND EAR INFIRMARY
399 REVOLUTION DRIVESOMERVILLEMA02145PCCHILD HEALTH RESEARCH AWARD - GENE THERAPY FOR PERIPHERAL NERVE REPAIR$82,500
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
C/O BANK OF AMERICA NA 100 FEDERALBOSTONMA02110PCCHILD HEALTH RESEARCH AWARD - A CIRCULATORY SUPPORT DEVICE FOR CHILDREN WITH UNIVENTRICULAR HEARTS AND FAILING FONTAN PHYSIOLOGY$82,500STREET
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - PEDIATRIC OPIOID POISONING: FAMILY, HOME, AND COMMUNITY RISK FACTORS$82,500
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655PCCHILD HEALTH RESEARCH AWARD - SINGLE-CELL TRANSCRIPTOMIC AND GENOMIC ANALYSIS OF HUMAN ATAXIA$82,500
UNIVERSITY OF CONNECTICUT HEALTH CENTER
263 FARMINGTON AVE MC5335FARMINGTONCT060305335PCCHILD HEALTH RESEARCH AWARD - HARNESSING MICROBIOME CONSTITUENTS TO PREVENT RECURRENT PEDIATRIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS$82,500
UNIVERSITY OF MASSACHUSETTS
55 LAKE AVENUE NORTHWORCESTERMA01655PCCHILD HEALTH RESEARCH AWARD - THE ROLE OF CUTANEOUS INTRINSIC IMMUNITY IN NEONATAL ANTIVIRAL DEFENSE$82,500
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - UNDERSTANDING THE ROLE OF ENVIRONMENTAL XENOBIOTICS IN FOOD ALLERGY$82,500
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH SUPPLEMENTAL ASSISTANCE DUE TO COVID IMPACTS - DEFINING A CILIA-LYSOSOME AXIS IN DEVELOPMENTAL SIGNALING AND CILIUM-BASED DISEASE$12,362
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655PCCHILD HEALTH SUPPLEMENTAL ASSISTANCE DUE TO COVID IMPACTS - IDENTIFICATION OF THE EMBRYONIC LYMPHOID PROGENITORS OF NEONATAL IL-17 PRODUCING T CELLS$18,694
BOSTON CHILDRENS HOSPITAL
PO BOX 414413BOSTONMA022414413PCCHILD HEALTH SUPPLEMENTAL ASSISTANCE DUE TO COVID IMPACTS - A MOBILE APPLICATION TO ENGAGE FAMILIES OF HOSPITALIZED CHILDREN IN SAFETY REPORTING$44,026
UNIVERSITY OF CONNECTICUT HEALTH CENTER
263 FARMINGTON AVE MC5335FARMINGTONCT060305335PCCHILD HEALTH SUPPLEMENTAL ASSISTANCE DUE TO COVID IMPACTS - ESTABLISHING THE C1Q-LIKE PROTEIN SIGNALING PATHWAY AS A NOVEL TARGET FOR ADHD TREATMENTS$11,795
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA NA PO BOXBOSTONMA022414876PCCHILD HEALTH SUPPLEMENTAL ASSISTANCE DUE TO COVID IMPACTS - GENETIC ETIOLOGY STUDY OF NEUROENDOCRINE CELL HYPERPLASIA OF INFANCY (NEHI) ON DISH$33,000414876
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA NA PO BOXBOSTONMA022414876PCCHILD HEALTH SUPPLEMENTAL ASSISTANCE DUE TO COVID IMPACTS - PROTECTIVE ANTIBODIES IN IMMUNOTHERAPY FOR PEANUT ALLERGY$24,200414876
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH SUPPLEMENTAL ASSISTANCE DUE TO COVID IMPACTS - MECHANISM OF CHIMERIC ANTIGEN RECEPTOR (CAR) SIGNALING$40,135
UNIVERSITY OF CONNECTICUT
438 WHITNEY RD EXT UNIT 1133STORRSCT06269PCCHILD HEALTH RESEARCH AWARD - NEXT GENERATION TARGETING OF ONCOMIRS FOR PEDIATRIC GLIOMA THERAPY$82,500
BOSTON CHILDRENS HOSPITAL
PO BOX 414413BOSTONMA022414413PCCHILD HEALTH RESEARCH AWARD - BACK TO THE BASICS OF ANTI-FOLATE THERAPY FOR IMPROVED CURE OF PEDIATRIC CANCER$82,500
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - NOVEL MRI MARKERS TO PREDICT MULTIPLE SCLEROSIS IN CHILDREN AT RISK$82,500
HEALTH RESOURCES IN ACTION INC
2 BOYLSTON STREET 4TH FLOORBOSTONMA02116PCCHILD HEALTH AWARD FUNDS TO BE HELD IN ESCROW (FUNDS TO BE PAID TO GRANTEES AT A LATER DATE)$165,000
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413BOSTONMA022414413PCCHILD HEALTH RESEARCH AWARD - MTORC1 AS A MEDIATOR OF HEMOPHAGOCYTOSIS AND MACROPHAGE ACTIVATION SYNDROME$82,500
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVE BP437BOSTONMA022155450PCCHILD HEALTH RESEARCH AWARD - PRECISION MEDICINE FOR PEDIATRIC ACUTE LEUKEMIA$82,500
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA NA PO BOXBOSTONMA022414876PCCHILD HEALTH RESEARCH AWARD - MEDS2: MEDICATION EDUCATION FOR DOSING SAFETY$82,500414876
BOSTON MEDICAL CENTER
660 HARRISON AVE 2ND FLOORBOSTONMA021182908PCCHILD HEALTH RESEARCH AWARD - RISING SUICIDES IN BLACK CHILDREN WITH ADHD: THE ROLE OF DISCRIMINATION$82,500
TUFTS MEDICAL CENTER
800 WASHINGTON STREET TUFTS MC BOXBOSTONMA021111526PCCHILD HEALTH RESEARCH AWARD - SALIVARY TRANSCRIPTOMIC ANALYSIS TO UNDERSTAND SEX-DEPENDENT INFLAMMATORY EFFECTS OF PRENATAL OPIOID EXPOSURE ON THE BRAIN REWARD SIGNALING$82,500453
MCLEAN HOSPITAL
PO BOX 414248BOSTONMA022414248PCMAJOR GRANT - BRAIN/BEHAVIOR MECHANISMS OF IRRITABILITY AND SUICIDE IN CHILDREN AND ADOLESCENTS$225,000
FieldValueIRS element (for citing)
Total Grant Or Contri Pd Dur Yr$2,059,212TotalGrantOrContriPdDurYrAmt

Grant Or Contri Apprv For Fut GrantOrContriApprvForFutGrp (11 entries)

Address Line1RecipientUSAddress/AddressLine1TxtCityRecipientUSAddress/CityNmState AbbreviationRecipientUSAddress/StateAbbreviationCdZIPRecipientUSAddress/ZIPCdRecipient Foundation StatusRecipientFoundationStatusTxtGrant Or Contribution PurposeGrantOrContributionPurposeTxtAmtAmtAddress Line2RecipientUSAddress/AddressLine2Txt
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - PEDIATRIC OPIOID POISONING: FAMILY, HOME, AND COMMUNITY RISK FACTORS$82,500
UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL
55 LAKE AVENUE NORTHWORCESTERMA01655PCCHILD HEALTH RESEARCH AWARD - SINGLE-CELL TRANSCRIPTOMIC AND GENOMIC ANALYSIS OF HUMAN ATAXIA$82,500
UNIVERSITY OF CONNECTICUT HEALTH CENTER
263 FARMINGTON AVE MC5335FARMINGTONCT060305335PCCHILD HEALTH RESEARCH AWARD - HARNESSING MICROBIOME CONSTITUENTS TO PREVENT RECURRENT PEDIATRIC METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS INFECTIONS$82,500
UNIVERSITY OF MASSACHUSETTS
55 LAKE AVENUE NORTHWORCESTERMA01655PCCHILD HEALTH RESEARCH AWARD - THE ROLE OF CUTANEOUS INTRINSIC IMMUNITY IN NEONATAL ANTIVIRAL DEFENSE$82,500
YALE UNIVERSITY
PO BOX 1873NEW HAVENCT065081873PCCHILD HEALTH RESEARCH AWARD - UNDERSTANDING THE ROLE OF ENVIRONMENTAL XENOBIOTICS IN FOOD ALLERGY$82,500
BOSTON CHILDREN'S HOSPITAL
PO BOX 414413BOSTONMA022414413PCCHILD HEALTH RESEARCH AWARD - MTORC1 AS A MEDIATOR OF HEMOPHAGOCYTOSIS AND MACROPHAGE ACTIVATION SYNDROME$82,500
DANA-FARBER CANCER INSTITUTE
450 BROOKLINE AVE BP437BOSTONMA022155450PCCHILD HEALTH RESEARCH AWARD - PRECISION MEDICINE FOR PEDIATRIC ACUTE LEUKEMIA$82,500
MASSACHUSETTS GENERAL HOSPITAL
C/O BANK OF AMERICA NA PO BOXBOSTONMA022414876PCCHILD HEALTH RESEARCH AWARD - MEDS2: MEDICATION EDUCATION FOR DOSING SAFETY$82,500414876
BOSTON MEDICAL CENTER
660 HARRISON AVE 2ND FLOORBOSTONMA021182908PCCHILD HEALTH RESEARCH AWARD - RISING SUICIDES IN BLACK CHILDREN WITH ADHD: THE ROLE OF DISCRIMINATION$82,500
TUFTS MEDICAL CENTER
800 WASHINGTON STREET TUFTS MC BOXBOSTONMA021111526PCCHILD HEALTH RESEARCH AWARD - SALIVARY TRANSCRIPTOMIC ANALYSIS TO UNDERSTAND SEX-DEPENDENT INFLAMMATORY EFFECTS OF PRENATAL OPIOID EXPOSURE ON THE BRAIN REWARD SIGNALING$82,500453
MCLEAN HOSPITAL
PO BOX 414248BOSTONMA022414248PCMAJOR GRANT - BRAIN/BEHAVIOR MECHANISMS OF IRRITABILITY AND SUICIDE IN CHILDREN AND ADOLESCENTS$225,000
FieldValueIRS element (for citing)
Total Grant Or Contri Apprv Fut$1,050,000TotalGrantOrContriApprvFutAmt

Analysis Income Producing Acty AnalysisIncomeProducingActyGrp

Div And Int From Sec Part VII DivAndIntFromSecPartVIIGrp

FieldValueIRS element (for citing)
Exclusion14ExclusionCd
Exclusion$1,302,685ExclusionAmt

Gain Sales Ast Oth Than Invntry GainSalesAstOthThanInvntryGrp

FieldValueIRS element (for citing)
Exclusion18ExclusionCd
Exclusion$860,251ExclusionAmt

Other Revenue Described OtherRevenueDescribedGrp (2 entries)

DescDescRelated Or Exempt Function IncmRelatedOrExemptFunctionIncmAmt
RETURNED GRANT FUNDS$175,535
MISCELLANEOUS INCOME$4,479

Subtotals Incm Producing Acty SubtotalsIncmProducingActyGrp

FieldValueIRS element (for citing)
Unrelated Business Taxbl Incm$0UnrelatedBusinessTaxblIncmAmt
Exclusion$2,162,936ExclusionAmt
Related Or Exempt Function Incm$180,014RelatedOrExemptFunctionIncmAmt
FieldValueIRS element (for citing)
Total Income Producing Acty$2,342,950TotalIncomeProducingActyAmt

Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp

Rln Of Acty To Accom Of Exmpt Prps RlnOfActyToAccomOfExmptPrpsGrp (2 entries)

Line NumberLineNumberTxtRelationship StatementRelationshipStatementTxt
11EXCESS FUNDS RETURNED FROM GRANTS PREVIOUSLY PAID OUT.
11MISCELLANEOUS NON-INVESTMENT INCOME

Trnsfr Trans Rln Nonchrtbl EO TrnsfrTransRlnNonchrtblEOGrp

FieldValueIRS element (for citing)
Trnsfr Of Cash To Nonchrtbl EO0TrnsfrOfCashToNonchrtblEOInd
Trnsfr Other Asset Nonchrtbl EO0TrnsfrOtherAssetNonchrtblEOInd
Sales Or Exchanges Of Assets0SalesOrExchangesOfAssetsInd
Purchase Of Assets Nonchrtbl EO0PurchaseOfAssetsNonchrtblEOInd
Rental Of Facilities Oth Assets0RentalOfFacilitiesOthAssetsInd
Reimbursement Arrangements0ReimbursementArrangementsInd
Loans Or Loan Guarantees0LoansOrLoanGuaranteesInd
Performance Of Services Etc0PerformanceOfServicesEtcInd
Sharing Of Facilities Etc0SharingOfFacilitiesEtcInd
Relationships Nonchrtbl EO0RelationshipsNonchrtblEOInd

Accounting Fees Schedule AccountingFeesSchedule

Accounting Fees Detail AccountingFeesDetail

FieldValueIRS element (for citing)
CategoryACCOUNTING & TAX PREPARATION FEESCategoryTxt
Amt$16,253Amt
Net Investment Income$0NetInvestmentIncomeAmt
Disbursements Charitable Prps$16,253DisbursementsCharitablePrpsAmt

All Oth Prog Rltd Investments Sch AllOthProgRltdInvestmentsSch

All Other Program Related Invst AllOtherProgramRelatedInvstGrp (2 entries)

DescDescAmtAmt
149 MEDICAL - BOLTON, MA UNSECURED CONVERTIBLE PROMISSORY NOTE$150,000
BIOROSA TECHNOLOGIES - BELMONT, MA UNSECURED CONVERTIBLE PROMISSORY NOTE$150,000

Expenditure Responsibility Stmt ExpenditureResponsibilityStmt

Expenditure Responsibility ExpenditureResponsibilityGrp (12 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdGrantGrantDtGrantGrantAmtPurpose Of GrantPurposeOfGrantTxtExpended By GranteeExpendedByGranteeAmtAny Diversion By GranteeAnyDiversionByGranteeTxtDates Of Reports By GranteeDatesOfReportsByGranteeTxtVerificationVerificationDtResults Of VerificationResultsOfVerificationTxtAddress Line2USAddress/AddressLine2TxtAddress Line1ForeignAddress/AddressLine1TxtCityForeignAddress/CityNmProvince Or StateForeignAddress/ProvinceOrStateNmCountryForeignAddress/CountryCdForeign PostalForeignAddress/ForeignPostalCd
NONINVASIX INC
1700 THE STRAND SUITE 1200GALVESTONTX775552017-07-27$7,000TO FUND NONINVASIX'S PARTICIPATION IN THE PHILIPS' MATERNAL AND INFANT HEALTHWORKS START-UP PROGRAM.$7,000NONE, SEE BELOWPRI REPORTS - 04/16/2020, 07/31/2020, 10/30/2020, 02/18/20212017-12-15THE TRUSTEES MEET WITH NONIVASIX, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BREEGI SCIENTIFIC INC
120 BEDFORD ROADWOBURNMA018012017-06-26$250,000THE FUNDS WILL BE USED TO CONDUCT A THOROUGH CLINICAL ASSESSMENT OF BSI'S NOVEL NEONATAL INTENSIVE CARE INCUBATOR "(NICI)" IN HONDURAS AND ZAMBIA AND TO AID THE COMMERCIALIZATION EFFORTS OF THIS LIFE-SAVING MEDICAL DEVICE.$250,000NONE, SEE BELOWPRI REPORTS - 03/19/2020, 09/14/2020, 08/02/2021, 08/12/20212021-08-02THE TRUSTEES MEET WITH BREEGI SCIENTIFIC, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
NONINVASIX INC
1700 THE STRAND SUITE 1200GALVESTONTX775552015-12-30$150,000TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORTS - 04/16/2020, 07/31/2020, 10/30/2020, 02/18/20212017-12-15THE TRUSTEES MEET WITH NONIVASIX, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
ALDATU BIOSCIENCES INC
C/O ARSENAL LAB SPACE 201 DEXTERWATERTOWNMA024722016-02-23$100,000TO SUPPORT THE USE AND DEVELOPMENT OF A SIMPLE, RAPID, THERMOSTABLE KIT THAT IDENTIFIES CLINICALLY ACTIONABLE HIV MUTATIONS FOUND IN PATIENTS FAILING A FIRST-LINE DRUG REGIMEN, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$100,000NONE, SEE BELOWPRI REPORTS - 04/15/2020, 05/19/2021, 05/25/20212017-12-15THE TRUSTEES MEET WITH ALDATU BIOSCIENCES, INC. MANAGEMENT ON A REGULAR BASIS AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.AVE
NONINVASIXINC
1700 THE STRAND SUITE 1200GALVESTONTX775552016-07-27$150,000TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S PEDIATRIC BRAIN OXYGENATION MONITORING SYSTEM, WHICH HAS THE POTENTIAL TO MORE ACCURATELY ASSESS THE RISK OF BRAIN HYPOXIA IN FETUSES AND NEONATES, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORT - 04/16/2020, 07/31/2020, 10/30/2020, 02/18/20212017-12-15THE TRUSTEES MEET WITH NONIVASIX, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
THINKMD INC
166 MAIN STREETBURLINGTONVT054012018-05-17$150,000FOR DEVELOPING INTEGRATED CLINICAL ASSESSMENT AND DATA ANALYTICS PLATFORMS AND OTHER DERIVATIVE PRODUCTS THAT TRANSFORM POINT-OF-CARE MEDICINE BY PUTTING VALIDATED CLINICAL ASSESSMENT CAPABILITY AND INCREASED HEALTHCARE KNOWLEDGE INTO THE HANDS OF CLINICALLY UNTRAINED HEALTHCARE PROFESSIONALS AND FAMILIES.$150,000NONE, SEE BELOWPRI REPORTS - 04/16/2020, 08/18/2020, 02/18/2021, 05/17/20212019-02-11THE TRUSTEES MEET WITH THINKMD, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
PRAPELA LLC
2 MAIN STREETBIDDEFORDME040052018-07-02$250,000THE PROCEEDS OF THE SALE AND ISSUANCE OF THE NOTES SHALL BE USED ONLY TO SUPPORT THE USE AND DEVELOPMENT OF THE COMPANY'S SLEEP TECHNOLOGY PRODUCTS FOR IMPROVING THE HEALTH OF INFANTS WHO COULD BENEFIT FROM WITHDRAWAL TREATMENT AND POST-WITHDRAWAL SUPPORT OF NEONATAL ABSTINENCE SYNDROME ("NAS") - A CONDITION CAUSED BY THE PRENATAL USE OF OPIOIDS OR OTHER DRUGS BY PREGNANT WOMEN.$250,000NONE, SEE BELOWPRI REPORTS - 09/10/2020, 06/02/20212020-09-10THE TRUSTEES MEET WITH PRAPELA, LLC MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
STINGRAY THERAPEUTICS
2450 HOLCOMBE BLVD SUITE XHOUSTONTX770212019-04-08$250,000FUNDS WILL BE USED FOR PRECLINICAL WORK FOCUSED ON PEDIATRIC BRAIN CANCERS, INCLUDING WORK TO DEVELOP PRECLINICAL MODELS AND TO TEST COMPOUNDS AGAINST MEDULLOBLASTOMA, TO TEST BLOOD BRAIN BARRIER PENETRATION, TO TEST WHETHER BLOOD BRAIN BARRIER PENETRATION IS EVEN NEEDED, AND IN PARALLEL, TO DO THE REGULATORY STUDIES REQUIRED TO FILE AN IND TO STUDY IN A PHASE 1-2 CLINICAL SETTING AND THE DRUG SUBSTANCE AND DRUG PRODUCT DEVELOPMENT AND MANUFACTURING REQUIRED FOR, AND TO BE USED SOLELY FOR THE PURPOSES OF, CLINICAL STUDY.$250,000NONE, SEE BELOWPRI REPORTS - 1/19/20, 7/15/20, 8/27/20, 10/7/20, 1/22/21, 4/15/21, 5/18/212021-05-18THE TRUSTEES MEET WITH STINGRAY THERAPEUTICS MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY.
149 MEDICAL INC
1173 MAIN STREETBOLTONMA017402020-04-17$150,000TO SUPPORT THE PRE-COMMERCIALIZATION DEVELOPMENT OF A MONITOR THAT MEASURES REAL-TIME BRAIN HEMODYNAMICS AND METABOLISM IN PRETERM NEWBORNS, IN AN ATTEMPT TO CHANGE THE STANDARD OF CARE BY IMPROVING LIVES, REDUCING MEDICAL ERRORS, AND REDUCING OVERALL HEALTHCARE COSTS, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$145,921NONE, SEE BELOWPRI REPORT - 04/27/2020, 07/27/2020, 12/10/2020, 06/08/20212021-06-08THE TRUSTEES MEET WITH 149 MEDICAL, INC. ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
ANIDA PHARMA INC
155 BROOKLINE STREET SUITE 005CAMBRIDGEMA021392020-12-21$250,000TO SUPPORT THE PRECLINICAL DEVELOPMENT OF A PREVENTATIVE TREATMENT FOR RETINOPATHY OF PREMATURITY, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND RELIEF OF THE POOR, DISTRESSED AND UNDERPRIVILEGED.$40,000NONE, SEE BELOWPRI REPORT - 12/31/20202021-05-24THE TRUSTEES MEET WITH ANIDA PHARMA, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
BIOROSA TECHNOLOGIES INC
63 BAKER STREETBELMONTMA024782020-07-15$150,000TO SUPPORT THE DEVELOPMENT OF A BLOOD-BASED STANDARD-OF-CARE DIAGNOSTIC FOR AUTISM SPECTRUM DISORDERS ("ASD") THAT IS INTENDED TO LEAD TO EARLIER DETECTION OF ASD THAN IS CURRENTLY AVAILABLE, THEREBY SUPPORTING THE ADVANCEMENT OF SCIENCE AND LESSENING THE BURDEN OF THE GOVERNMENT.$150,000NONE, SEE BELOWPRI REPORTS - 02/04/2021, 06/17/20212021-07-16THE TRUSTEES MEET WITH BIOROSA TECHNOLOGIES, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY
MESENTECH INC
2020-11-02$250,000TO SUPPORT THE ADVANCEMENT OF SCIENCE AND PROMOTION OF HEALTH THROUGH THE PRECLINICAL RESEARCH OF ANABOLIC BONE THERAPEUTICS THAT CAN INCREASE BONE MASS TO STRENGTHEN THE SKELETON AND THE DEVELOPMENT OF A DRUG DELIVERY SYSTEM TO BE INITIALLY APPLIED TO TWO PEDIATRIC RARE DISEASES: OSTEOGENESIS IMPERFECTA AND DUCHENNE MUSCULAR DYSTROPHY.$80,755NONE, SEE BELOWPRI REPORT - 05/18/20212021-05-18THE TRUSTEES MEET WITH MESENTECH, INC. MANAGEMENT ON A REGULAR BAS1S, ATTEND BOARD MEETINGS AS AN OBSERVER AND REVIEW THE PRI REPORTS AND FINANCIALS. TO THE TRUSTEES KNOWLEDGE, THE GRANTEE HAS NOT DIVERTED ANY OF THE FUNDS FROM THE PURPOSE OF THE GRANT. NO ADDITIONAL FOLLOW UP DEEMED NECESSARY2222 HEALTH SCIENCES RDVANCOUVERBRITISH COLUMBIACAV6T2B9

Investments Corp Bonds Schedule InvestmentsCorpBondsSchedule

Investments Corporate Bonds InvestmentsCorporateBondsGrp

FieldValueIRS element (for citing)
BondFIXED INCOMEBondNm
EOY Book Value$15,513,323EOYBookValueAmt
EOYFMV$15,513,323EOYFMVAmt

Investments Corp Stock Schedule InvestmentsCorpStockSchedule

Investments Corporate Stock InvestmentsCorporateStockGrp (2 entries)

StockStockNmEOY Book ValueEOYBookValueAmtEOYFMVEOYFMVAmt
DOMESTIC EQUITIES$36,997,735$36,997,735
FOREIGN SECURITIES$14,983,000$14,983,000

Investments Other Schedule2 InvestmentsOtherSchedule2

Investments Other InvestmentsOtherGrp (2 entries)

Category Or ItemCategoryOrItemTxtListed At Cost Or FMVListedAtCostOrFMVCdBook ValueBookValueAmtEOYFMVEOYFMVAmt
REAL ESTATEFMV$2,863,191$2,863,191
ALTERNATIVE INVESTMENTSFMV$602,701$602,701

Legal Fees Schedule LegalFeesSchedule

Legal Fees LegalFeesGrp

FieldValueIRS element (for citing)
CategoryLEGAL EXPENSESCategoryTxt
Legal Fees$28,703LegalFeesAmt
Net Investment Income$0NetInvestmentIncomeAmt
Disbursements Charitable Prps$28,703DisbursementsCharitablePrpsAmt

Other Assets Schedule OtherAssetsSchedule

Other Assets Schedule OtherAssetsScheduleGrp

FieldValueIRS element (for citing)
DescPROGRAM RELATED INVESTMENTSDesc
BOY Book Value$1,307,000BOYBookValueAmt
EOY Book Value$2,119,964EOYBookValueAmt
EOYFMV$2,119,964EOYFMVAmt

Other Decreases Schedule OtherDecreasesSchedule

Other Decreases Detail OtherDecreasesDetail (4 entries)

DescDescAmtAmt
LOSS ON INVESTMENT IN GPG HEALTHCARE OPPORTUNITIES FUND, LLC$29,753
LOSS ON INVESTMENT IN NEWBURY EQUITY PARTNERS V L.P.$22,253
LOSS ON INVESTMENT IN ACCOLADE PARTNERS VIII, L.P.$8,569
LOSS ON RCP FUND XIV CAYMAN FEEDER, LP$55,783

Other Expenses Schedule OtherExpensesSchedule

Other Expenses Schedule OtherExpensesScheduleGrp (7 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
FILING FEES$1,039$0$1,039
MISCELLANEOUS EXPENSES$5,670$0$5,669
HRIA ADMINISTRATIVE COSTS$131,820$0$131,821
PROGRAM RELATED INVESTMENT ADMINISTRATIVE COSTS$7,404$0$7,404
MARKETING$851$0$851
HONORARIA$21,238$0$21,238
SCIENTIFIC ADVISORS$42,742$0$42,742

Other Income Schedule2 OtherIncomeSchedule2

Other Income Detail OtherIncomeDetail (2 entries)

DescDescRevenue And Expenses Per BooksRevenueAndExpensesPerBooksAmtAdjusted Net IncomeAdjustedNetIncomeAmt
RETURNED GRANT FUNDS$175,535$175,535
MISCELLANEOUS INCOME$4,479$4,479

Other Increases Schedule OtherIncreasesSchedule

Other Increases Detail OtherIncreasesDetail

FieldValueIRS element (for citing)
DescUNREALIZED GAINSDesc
Amt$6,877,676Amt

Other Professional Fees Schedule OtherProfessionalFeesSchedule

Other Professional Fees Detail OtherProfessionalFeesDetail (2 entries)

CategoryCategoryTxtAmtAmtNet Investment IncomeNetInvestmentIncomeAmtDisbursements Charitable PrpsDisbursementsCharitablePrpsAmt
INVESTMENT FEES - US TRUST$31,525$15,762$15,763
INVESTMENT CONSULTING$75,000$75,000$0

Taxes Schedule TaxesSchedule

Taxes Detail TaxesDetail

FieldValueIRS element (for citing)
CategoryFOREIGN TAXESCategoryTxt
Amt$36,521Amt
Net Investment Income$36,521NetInvestmentIncomeAmt
Disbursements Charitable Prps$0DisbursementsCharitablePrpsAmt

Comments

Anonymous: no account or email. Up to 2,000 characters, at most one link. Comments are checked automatically; some wait for review.